Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol.

PubWeight™: 1.98‹?› | Rank: Top 2%

🔗 View Article (PMID 3306386)

Published in N Engl J Med on October 01, 1987

Authors

P C de Groen, A J Aksamit, J Rakela, G S Forbes, R A Krom

Articles citing this

Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc Natl Acad Sci U S A (2003) 2.62

Role of formulation vehicles in taxane pharmacology. Invest New Drugs (2001) 1.58

Peripheral neuropathy induced by paclitaxel: recent insights and future perspectives. Curr Neuropharmacol (2006) 1.53

Cerebral aspergillosis in liver transplantation. J Clin Pathol (1990) 1.40

Neurologic complications of FK 506. Transplant Proc (1991) 1.34

Progressive neurological disease induced by tacrolimus in a renal transplant recipient: case presentation. BMC Nephrol (2006) 1.15

Cyclosporin-associated akinetic mutism and extrapyramidal syndrome after liver transplantation. J Neurol Neurosurg Psychiatry (1990) 1.07

Expressive dysphasia possibly related to FK506 in two liver transplant recipients. Transplantation (1990) 1.04

Therapeutic window analysis of the neuroprotective effects of cyclosporine A after traumatic brain injury. J Neurotrauma (2011) 0.98

Neurological complications after cadaveric and living donor liver transplantation. J Neurol (2006) 0.95

Neuropathologic findings after liver transplantation. Acta Neuropathol (1992) 0.90

Increased incidence of neurological complications in patients receiving an allogenic bone marrow transplantation from alternative donors. J Neurol Neurosurg Psychiatry (2000) 0.89

Focal hepatic encephalopathy with status epilepticus: incomplete recovery after hepatic transplantation. Dig Dis Sci (1997) 0.87

Central pontine myelinolysis in liver transplantation. J Clin Pathol (1991) 0.86

Cyclosporin for refractory ulcerative colitis. Gut (2003) 0.85

The novel immunosuppressant SDZ-RAD protects rat brain slices from cyclosporine-induced reduction of high-energy phosphates. Br J Pharmacol (2000) 0.85

Inhibition of calcineurin in the prefrontal cortex induced depressive-like behavior through mTOR signaling pathway. Psychopharmacology (Berl) (2012) 0.84

Adverse effect of cyclosporin A on barrier functions of cerebral microvascular endothelial cells after hypoxia-reoxygenation damage in vitro. Cell Mol Neurobiol (2007) 0.82

Neurologic complications in adult living donor liver transplant patients: an underestimated factor? J Neurol (2009) 0.82

Cyclosporin associated headache. J Neurol Neurosurg Psychiatry (1994) 0.82

Nutrition in the management of cirrhosis and its neurological complications. J Clin Exp Hepatol (2013) 0.81

Targeted delivery of albumin bound paclitaxel in the treatment of advanced breast cancer. Onco Targets Ther (2009) 0.79

Treatment of hippocampal neurons with cyclosporin A results in calcium overload and apoptosis which are independent on NMDA receptor activation. Br J Pharmacol (2001) 0.79

Retracted Blockade of protein phosphatase 2B activity in the amygdala increases anxiety- and depression-like behaviors in mice. Biol Psychiatry (2009) 0.79

Progressive visual deterioration leading to blindness after pediatric heart transplantation. Tex Heart Inst J (1993) 0.78

Reprint of: Nutrition in the Management of Cirrhosis and its Neurological Complications. J Clin Exp Hepatol (2015) 0.76

Posterior Reversible Encephalopathy Syndrome: Local Experience From Saudi Arabia. Neurohospitalist (2016) 0.75

Central pontine myelinolysis following orthotopic liver transplant: association with cyclosporine toxicity. Postgrad Med J (1995) 0.75

Calcineurin downregulation in the amygdala is sufficient to induce anxiety-like and depression-like behaviors in C57BL/6J male mice. Biol Psychiatry (2014) 0.75

Role of plasma lipoproteins in modifying the toxic effects of water-insoluble drugs: studies with cyclosporine A. AAPS PharmSci (2002) 0.75

Adverse drug reaction profile of nanoparticle versus conventional formulation of paclitaxel: An observational study. Indian J Pharmacol (2011) 0.75

Headache in kidney transplantation. J Headache Pain (2009) 0.75

Synaptic Mitochondria Sustain More Damage than Non-Synaptic Mitochondria after Traumatic Brain Injury and Are Protected by Cyclosporine A. J Neurotrauma (2016) 0.75

Unusual cyclosporin related neurological complications in recipients of liver transplants. Arch Dis Child (1993) 0.75

Dose response of fish oil versus safflower oil on graft arteriosclerosis in rabbit heterotopic cardiac allografts. Ann Surg (1991) 0.75

Cyclosporin neurotoxicity in cardiac transplant recipient. J Neurol Neurosurg Psychiatry (1989) 0.75

Posterior Reversible Encephalopathy Syndrome in a Bone Marrow Transplant Patient: A Complication of Immunosuppressive Drugs? World J Oncol (2015) 0.75

Neuropsychiatric complications after liver transplantation: role of immunosuppression and hepatitis C. Dig Dis Sci (2006) 0.75

Imaging spectrum of central nervous system complications of hematopoietic stem cell and solid organ transplantation. Neuroradiology (2017) 0.75

Articles by these authors

Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet (2003) 11.91

A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology (2001) 5.16

Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology (2004) 4.74

A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology (1990) 4.02

MELD and PELD: application of survival models to liver allocation. Liver Transpl (2001) 3.76

Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group. Ann Intern Med (1996) 3.38

A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease. Am J Gastroenterol (1997) 2.65

The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology (1997) 2.57

Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg (1998) 2.31

Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl (2000) 2.27

Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology (1999) 2.19

The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients. Hepatology (1989) 2.19

Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg (1997) 2.16

Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations. Mayo Clin Proc (1989) 1.93

Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl (2000) 1.88

The mitotic checkpoint protein hBUB3 and the mRNA export factor hRAE1 interact with GLE2p-binding sequence (GLEBS)-containing proteins. J Biol Chem (2001) 1.84

A prospective comparison of molecular diagnostic techniques for the early detection of cytomegalovirus in liver transplant recipients. J Infect Dis (1995) 1.71

Detection of cytomegalovirus DNA in sera of liver transplant recipients. J Clin Microbiol (1994) 1.69

The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient. Liver Transpl Surg (1997) 1.68

Electronic imaging impact on image and report turnaround times. J Digit Imaging (1999) 1.66

Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes. J Infect Dis (2000) 1.66

Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology (1988) 1.65

Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues. Neurology (2011) 1.64

Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology (1996) 1.62

Choledochocholedochostomy, a relatively safe procedure in orthotopic liver transplantation. Surgery (1985) 1.61

Clinical and radiologic features of cerebral edema in fulminant hepatic failure. Mayo Clin Proc (1995) 1.59

Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation. Mayo Clin Proc (1994) 1.59

Embolization of spinal dural arteriovenous fistula with polyvinyl alcohol particles: experience in 14 patients. AJNR Am J Neuroradiol (1992) 1.57

Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis. Mayo Clin Proc (1990) 1.56

Liver transplantation for Wilson's disease: a single-center experience. Liver Transpl Surg (1999) 1.55

Cerebral aneurysms in childhood and adolescence. J Neurosurg (1989) 1.55

Persistent chorea triggered by hyperglycemic crisis in diabetics. Mov Disord (2001) 1.55

Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation. Hepatology (1993) 1.53

Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative-strand viral RNA in various tissues. Hepatology (1998) 1.49

Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology (1999) 1.49

Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: a prospective, randomized, double-blind study. Liver Transpl (2001) 1.48

The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy. Hepatology (1996) 1.48

Ischemic-type biliary complications after orthotopic liver transplantation. Hepatology (1992) 1.46

Optimal timing of liver transplantation for primary biliary cirrhosis. Hepatology (1998) 1.46

Unruptured intracranial aneurysms and arteriovenous malformations: frequency of intracranial hemorrhage and relationship of lesions. J Neurosurg (1990) 1.45

Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated autoimmune chronic active hepatitis. Mayo Clin Proc (1991) 1.44

Orthotopic liver transplantation for preoperative early-stage hepatocellular carcinoma. Mayo Clin Proc (1994) 1.43

The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl Surg (1998) 1.42

Magnetic resonance imaging of facial vascular anomalies. Mayo Clin Proc (1992) 1.41

The role of portosystemic shunts for variceal bleeding in the liver transplantation era. Arch Surg (1994) 1.40

Uneven distribution of hepatitis C virus quasispecies in tissues from subjects with end-stage liver disease: confounding effect of viral adsorption and mounting evidence for the presence of low-level extrahepatic replication. J Virol (2000) 1.40

Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated cryptogenic chronic active hepatitis. Mayo Clin Proc (1990) 1.39

A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B. Hepatology (2001) 1.29

Chronic liver disease after acute non-A, non-B viral hepatitis. Gastroenterology (1979) 1.28

Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation (1998) 1.28

Hepatitis C virus quasispecies in patients infected with HIV-1: correlation with extrahepatic viral replication. Virology (1998) 1.27

Lack of evidence for hepatitis G virus replication in the livers of patients coinfected with hepatitis C and G viruses. J Virol (1997) 1.26

Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology (1999) 1.26

Symptomatic subependymoma: a clinicopathological and flow cytometric study. J Neurosurg (1991) 1.23

Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation (1996) 1.22

Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet (1993) 1.21

Cytomegalovirus hepatitis in liver transplantation: prospective analysis of 93 consecutive orthotopic liver transplantations. J Infect Dis (1989) 1.19

The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation. Hepatology (1987) 1.19

Cytomegalovirus PP65 antigenemia monitoring as a guide for preemptive therapy: a cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients. Transplantation (1999) 1.19

Hepatits A virus infection in fulminant hepatitis and chronic active hepatitis. Gastroenterology (1978) 1.19

Diagnostic features and clinical outcome of ischemic-type biliary complications after liver transplantation. Hepatology (1993) 1.18

Treatment of highly symptomatic polycystic liver disease. Preliminary experience with a combined hepatic resection-fenestration procedure. Ann Surg (1990) 1.18

Hepatitis C virus negative strand RNA is not detected in peripheral blood mononuclear cells and viral sequences are identical to those in serum: a case against extrahepatic replication. J Gen Virol (1997) 1.17

Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group. Hepatology (1999) 1.17

A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim report. Transplantation (1998) 1.16

FK506-induced neurotoxicity in liver transplantation. Ann Neurol (1994) 1.16

Detection of active hepatitis C virus and hepatitis G virus/GB virus C replication in bone marrow in human subjects. Blood (2000) 1.16

"Angioglioma" and the arteriovenous malformation-glioma association. J Neurosurg (1991) 1.15

Progressive multifocal leukoencephalopathy: investigation of three cases using in situ hybridization with JC virus biotinylated DNA probe. Ann Neurol (1985) 1.15

Endoscopic application of photodynamic therapy for cholangiocarcinoma. Gastrointest Endosc (2001) 1.14

Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection. Hepatology (1994) 1.14

Outcome of the use of pediatric donor livers in adult recipients. Liver Transpl (2001) 1.14

Antibodies to hepatitis A virus: patterns by two procedures. J Clin Microbiol (1977) 1.14

Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology (1999) 1.14

Exposure of hepatitis C virus (HCV) RNA-positive recipients to HCV RNA-positive blood donors results in rapid predominance of a single donor strain and exclusion and/or suppression of the recipient strain. J Virol (2001) 1.12

Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: case reports and literature review. Mayo Clin Proc (1997) 1.12

Hepatitis B virus core promoter sequence analysis in fulminant and chronic hepatitis B. Gastroenterology (1995) 1.12

Fulminant Wilson's disease treated with postdilution hemofiltration and orthotopic liver transplantation. Gastroenterology (1986) 1.12

Increased bile duct complications in liver transplantation across the ABO barrier. Ann Surg (1993) 1.11

Complications of liver biopsy in liver transplant patients: increased sepsis associated with choledochojejunostomy. Hepatology (1991) 1.11

Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology (1991) 1.10

Progressive multifocal leukoencephalopathy: JC virus detection by in situ hybridization compared with immunohistochemistry. Neurology (1986) 1.10

Influence of positive lymphocyte crossmatch and HLA mismatching on vanishing bile duct syndrome in human liver allografts. Transplantation (1988) 1.10

Bone disease in liver transplant recipients: incidence, timing, and risk factors. Transplant Proc (1991) 1.10

Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors. Transplantation (1999) 1.09

Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. Hepatology (1998) 1.09

Choledochocholedochostomy is successful in orthotopic liver transplantation. Transplant Proc (1984) 1.09

Absence of hepatitis B virus DNA detected by polymerase chain reaction in blood donors who are hepatitis B surface antigen negative and antibody to hepatitis B core antigen positive from a United States population with a low prevalence of hepatitis B serologic markers. Transfusion (1993) 1.08

Splenic artery aneurysms in liver transplant patients. Transplantation (1988) 1.08

Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology (1992) 1.08

Fatal hepatotoxicity associated with troglitazone. Ann Intern Med (1998) 1.07

Delayed immune hemolysis in a patient receiving cyclosporine after orthotopic liver transplantation. Transfusion (1988) 1.07

Detection of hepatitis C virus replication in peripheral blood mononuclear cells after orthotopic liver transplantation. Transplantation (1998) 1.07

Efficacy of ganciclovir in liver and kidney transplant recipients with severe cytomegalovirus infection. Transplantation (1988) 1.06

Orbital volume measurements in enophthalmos using three-dimensional CT imaging. Plast Reconstr Surg (1985) 1.06